SCHEMBL5862802

SCHEMBL5862802

CS(=O)(=O)N(Cc1ccccc1)C1COc2c(cc(C#N)cc2[N+](=O)[O-])C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FNTA P49354 6/20 0.44
FNTB P49356 6/20 0.44
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
TLR9 Q9NR96 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
SLC6A2 P23975 3/20 0.34
SLC6A4 P31645 3/20 0.34
KCNH2 Q12809 3/20 0.34
SLC6A3 Q01959 2/20 0.34
SNCA P37840 2/20 0.34
PIK3CD O00329 1/20 0.33
PIK3CA P42336 1/20 0.33
F10 P00742 1/20 0.33
DPP4 P27487 1/20 0.33
DPP9 Q86TI2 1/20 0.33
DPP7 Q9UHL4 1/20 0.33
MAPK1 P28482 1/20 0.32
CYP19A1 P11511 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5862858 0.88 FNTA (0.38) FNTAFNTBSLC6A2SLC6A4KCNH2
SCHEMBL5860941 0.85 FNTA (0.47) FNTAFNTBSLC6A2SLC6A4KCNH2
SCHEMBL5861352 0.83 FNTA (0.46) FNTAFNTBSLC6A2SLC6A4KCNH2
SCHEMBL5860957 0.77 FNTA (0.46) FNTAFNTBSLC6A2SLC6A4KCNH2
SCHEMBL5862857 0.76 FNTA (0.45) FNTAFNTBSLC6A2SLC6A4KCNH2
SCHEMBL5862889 0.76 FNTA (0.45) FNTAFNTBSLC6A2SLC6A4KCNH2
SCHEMBL5860858 0.75 FNTA (0.54) FNTAFNTB
SCHEMBL5862162 0.75 FNTA (0.60) FNTAFNTB
SCHEMBL5862851 0.75 FNTA (0.44) FNTAFNTB
SCHEMBL5862248 0.75 FNTA (0.54) FNTAFNTB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7053223-B2 Inhibitors of farnesyl protein transferase BRISTOL-MYERS SQUIBB COMPANY (US) 2006-05-30 US disclosed
US-20040181068-A1 Inhibitors of farnesyl protein transferase BRISTOL-MYERS SQUIBB COMPANY 2004-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040181068-A1 Inhibitors of farnesyl protein transferase FNTA, FNTB, ACAT2 FNTA 1/4885FNTB 2/4885NPC1 39/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.